European Journal of Cancer
Volume 39, Issue 9 , Pages 1318-1329, June 2003

Trail-induced apoptosis and interaction with cytotoxic agents in soft tissue sarcoma cell lines

  • S Tomek

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +43-1-40400-4445; fax: +43-1-40400-4452
    • ,
  • W Koestler

      Affiliations

    • Clinical Division of Oncology, Department of Medicine I, Waehringer Guertel 18-20, A-1090 Vienna, Austria
    • ,
  • P Horak

      Affiliations

    • Clinical Division of Oncology, Department of Medicine I, Waehringer Guertel 18-20, A-1090 Vienna, Austria
    • ,
  • T Grunt

      Affiliations

    • Clinical Division of Oncology, Department of Medicine I, Waehringer Guertel 18-20, A-1090 Vienna, Austria
    • ,
  • T Brodowicz

      Affiliations

    • Clinical Division of Oncology, Department of Medicine I, Waehringer Guertel 18-20, A-1090 Vienna, Austria
    • ,
  • I Pribill

      Affiliations

    • Clinical Division of Oncology, Department of Medicine I, Waehringer Guertel 18-20, A-1090 Vienna, Austria
    • ,
  • J Halaschek

      Affiliations

    • Clinical Division of Oncology, Department of Medicine I, Waehringer Guertel 18-20, A-1090 Vienna, Austria
    • ,
  • G Haller

      Affiliations

    • Clinical Division of Oncology, Department of Medicine I, Waehringer Guertel 18-20, A-1090 Vienna, Austria
    • ,
  • C Wiltschke

      Affiliations

    • Clinical Division of Oncology, Department of Medicine I, Waehringer Guertel 18-20, A-1090 Vienna, Austria
    • ,
  • C.C Zielinski

      Affiliations

    • Clinical Division of Oncology, Department of Medicine I, Waehringer Guertel 18-20, A-1090 Vienna, Austria
    • Ludwig Boltzmann Institute for Clinical Experimental Oncology, Vienna University Hospital, Waehringer Guertel 18-20, A-1090 Vienna, Austria
    • ,
  • M Krainer

      Affiliations

    • Clinical Division of Oncology, Department of Medicine I, Waehringer Guertel 18-20, A-1090 Vienna, Austria

Received 23 September 2002; received in revised form 10 February 2003; accepted 27 February 2003.

Full Text Available

  • Purchase this article for  31.50 USD

    Access is available for 24 hours.

    (Login or Register to purchase)

  • Subscribe to this title
  • Claim access now

    Current subscribers


    • PII: S0959-8049(03)00227-2

    doi:10.1016/S0959-8049(03)00227-2

    European Journal of Cancer
    Volume 39, Issue 9 , Pages 1318-1329, June 2003